Skip to content

Optimization and Innovation of Pulmonary Rehabilitation Protocols for Patients Undergoing Minimally Invasive Laparoscopic Surgery

Optimization and Innovation of Pulmonary Rehabilitation Protocols for Patients Undergoing Minimally Invasive Laparoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109262
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-09-16
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Experiment group:Standardized Baduanjin combined with breathing training commenced 48 hours post-operation, conducted three times per week (Monday, Wednesday, Friday) for a duration of 8 weeks. Three-
Control group:Commenced 48 hours post-operation, lasting 8 weeks, bedside cycling training conducted every Monday, Wednesday, and Friday at 9:00 AM. Initial intensity within first 2 weeks: 0 resistanc

Sponsors

Henan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 78 Years

Inclusion criteria

Inclusion criteria: (1)The diagnosis of primary lung cancer was confirmed by pathological examination and the clinical stage was I-IIIA. (2)First time undergoing thoracoscopic surgery. (3)Aged 35-78 years. (4)Normal cognitive level, good understanding and communication skills, able to understand and co-operate with rehabilitation training. (5)No regular participation in exercise training ( >= 3 sessions/week) in the past 6 months and no prior practice of Baduanjin/Qigong. (6)Voluntarily enrolled with signed informed consent.

Exclusion criteria

Exclusion criteria: (1)Combined with other malignant tumours. (2)Combined severe cardiac, pulmonary, hepatic, renal and other vital organ dysfunction. (3)Non-first surgery for lung cancer (such as previous secondary VATS procedures or open thoracic surgery history). (4)Those who are unable to complete the research project due to defective limbs or extreme physical weakness, etc. (5)Those with an expected survival time of <6 months. (6)Those with poor compliance and who withdrew from the study midway.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;

Secondary

MeasureTime frame
postoperative pain levels;Exercise tolerance;cancer-related fatigue;quality of life;

Countries

China

Contacts

Public ContactHaitao Wei; Li Li

Henan University

10210051@vip.henu.edu.cn+86 137 0378 6236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026